Atopic dermatitis is a Th2 disease, due to relapse of IL-4 and IL-13 by Th2 cells. Despite the
approval by FDA of dupilumab, the first monoclonal antibody for the severe forms, traditional …

Purpose of review Atopic dermatitis (AD) is a common chronic inflammatory relapsing skin
disease that greatly affects the quality of life of patients and their relatives. Topical treatment …

Atopic dermatitis (AD) is a prevalent inflammatory skin disorder affecting all age and ethnic
groups. The age-dependent varying appearance and extent of pruritic lesions are …

Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease with a life-time
prevalence of 10–20% in western countries. Patients suffer from stigmatizing eczematous …

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by relapsing
eczema and pruritus. Until the development of Dupilumab, a new monoclonal antibody …

Background: Atopic dermatitis (AD) can be debilitating and often requires the use of
combination topical and systemic therapy to achieve adequate disease control. Methods: A …

Atopic dermatitis (AD) is a chronic disorder that requires thorough patient education and a
therapeutic management strategy designed to control flares, decrease recurrences, and …

Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The
prevalence of AD is increasing and is currently estimated at 10–20% in adults worldwide. In …

The article focuses on chronic skin condition called Atopic dermatitis (AD) and its treatment.
Topics discussed include creation of a disturbed skin barrier created by inflammatory type 2 …

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory skin disease which predominately
affects children and usually clears up during infancy or childhood. However, AD may persist …